LEADER 01945nam  2200349   450 
001 9910688208703321
005 20230629165413.0
035   $a(CKB)5400000000043898
035   $a(NjHacI)995400000000043898
035   $a(EXLCZ)995400000000043898
100   $a20230629d2021      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aPseudomonas aeruginosa $eBiofilm Formation, Infections and Treatments /$fedited by Theerthankar Das
210  1$aLondon :$cIntechOpen,$d2021.
215   $a1 online resource (114 pages)
311   $a1-83968-649-9 
330   $aEmerging antibiotic resistance of bacteria is driving us to catastrophic failure of the healthcare system. Pseudomonas aeruginosa is one such pathogen that is responsible for causing nosocomial infections, urinary tract infections, cystic fibrosis, otitis media, and infections of wounds and burns. P. aeruginosa is a critical pathogen as defined by the World Health Organization (WHO) due to its intrinsic and adaptive competence to defy antibiotics and persist as a superbug. This book covers a wide array of subjects relevant to bacterial biofilms specifically focusing on P. aeruginosa and associated infections. It provides readers with a clear and comprehensive overview of biofilm formation and associated detrimental impacts. In addition, this book also examines topics related to biosynthesis virulence factors by P. aeruginosa to facilitate biofilm formation, antibiotic resistance mechanisms, and infections.
517   $aPseudomonas aeruginosa 
606   $aPseudomonas aeruginosa infections
615  0$aPseudomonas aeruginosa infections.
676   $a616.0145
702   $aDas$b Theerthankar
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688208703321
996   $aPseudomonas aeruginosa$92955174
997   $aUNINA